search
Back to results

Reduction of Falls in the Elderly - Parkinson's Disease (REFINE-PD)

Primary Purpose

Parkinson's Disease

Status
Completed
Phase
Phase 3
Locations
Netherlands
Study Type
Interventional
Intervention
Multifactorial fall prevention program
Usual care
Sponsored by
Radboud University Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Parkinson's Disease focused on measuring Accidental falls, Prevention, Treatment effectiveness

Eligibility Criteria

20 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients with idiopathic Parkinson's Disease, diagnosed according to the Brain Bank criteria of the UK Parkinson's Society
  • Regular control by the neurologist
  • Living independently in the community
  • Able to complete the trial questionnaires
  • An increased risk for falling, defined as:

    • at least one fall in the preceding 12 months OR
    • recurrent (monthly) near falls in the preceding 12 months OR
    • fear of falling OR (iv) avoidance of activities due to fear of falling OR a combination of these findings

Exclusion Criteria:

  • Atypical parkinsonian syndromes
  • Hoehn and Yahr stage 5
  • Severe cognitive impairment (MMSE < 24)
  • Severe co-morbidity (e.g., cancer)
  • Planned surgical procedure for PD within the intervention period
  • Patients who have already visited the Multidisciplinary Assessment Center

Sites / Locations

  • Ziekenhuis Groep Twente, Twenteborg Ziekenhuis
  • Ziekenhuis Rijnstate
  • Wilhelmina Ziekenhuis Assen
  • Ziekenhuis Groep Twente, Streekziekenhuis Midden-Twente
  • Medisch Centrum Leeuwarden
  • Canisius Wilhelmina Ziekenhuis

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

I

II

Arm Description

Multifactorial fall prevention program

Usual care

Outcomes

Primary Outcome Measures

Incidence of falls

Secondary Outcome Measures

Number of fallers (secondary)
Falls Efficacy Scale (tertiary)
Unified Parkinson's Disease rating scale (UPDRS) Motor Examination (part III) (tertiary)
Parkinson's Disease quality of life questionnaire (PDQL) (tertiary)
Self-assessment Parkinson's Disease disability scale (SPDDS)(tertiary)
Caregiver burden assessed with BELA-A-k, SF-36, and HADS (tertiary)
Number of injurious falls (secondary)
Number of patients with injurious falls (secondary)
Freezing of gait (tertiary)
Costs (secondary)

Full Information

First Posted
August 20, 2007
Last Updated
November 22, 2010
Sponsor
Radboud University Medical Center
Collaborators
National Parkinson Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT00518648
Brief Title
Reduction of Falls in the Elderly - Parkinson's Disease
Acronym
REFINE-PD
Official Title
Reduction of Falls in the Elderly - Parkinson's Disease
Study Type
Interventional

2. Study Status

Record Verification Date
November 2010
Overall Recruitment Status
Completed
Study Start Date
August 2007 (undefined)
Primary Completion Date
August 2010 (Actual)
Study Completion Date
August 2010 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Radboud University Medical Center
Collaborators
National Parkinson Foundation

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The REFINE-PD study is a controlled trial embedded within a larger cluster controlled study (the IMPACT study). The study aims to investigate the efficacy of a multifactorial falls prevention program for patients with Parkinson's Disease (PD). This program contains PD-specific elements (e.g., optimizing dopaminergic therapy), plus a generic falls prevention program. The intervention will be tailored to each individual's specific risk profile for falls, as identified during detailed baseline examination.
Detailed Description
Falls and postural instability are common complications of advanced Parkinson's Disease (PD). Falls in PD often have devastating consequences, leading to a poor overall prognosis. In addition, falls in PD are associated with substantial medical expenses due to treatment of injuries and nursing home admission. The risk of falls in older PD patients is aggravated by "generic" age-related factors, such as sedative medication or poor vision. Observations on elderly persons without PD suggest that a multifactorial prevention program might be more effective. We propose to investigate the effectiveness of a multifactorial prevention program aimed at the prevention of falls in PD, which is based on disease-specific treatment strategies with demonstrated efficacy in PD, as well as prevention strategies with proven effectiveness for the general elderly population. In this study an individualised multifactorial program aimed at the prevention of falls in PD containing PD-specific elements and a generic falls prevention program will be compared to usual care.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Parkinson's Disease
Keywords
Accidental falls, Prevention, Treatment effectiveness

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Non-Randomized
Enrollment
187 (Actual)

8. Arms, Groups, and Interventions

Arm Title
I
Arm Type
Experimental
Arm Description
Multifactorial fall prevention program
Arm Title
II
Arm Type
Other
Arm Description
Usual care
Intervention Type
Other
Intervention Name(s)
Multifactorial fall prevention program
Intervention Description
Individualised multifactorial fall prevention program containing PD-specific elements as well as generic elements
Intervention Type
Other
Intervention Name(s)
Usual care
Intervention Description
Usual care
Primary Outcome Measure Information:
Title
Incidence of falls
Time Frame
8 months
Secondary Outcome Measure Information:
Title
Number of fallers (secondary)
Time Frame
8 months
Title
Falls Efficacy Scale (tertiary)
Time Frame
8 months
Title
Unified Parkinson's Disease rating scale (UPDRS) Motor Examination (part III) (tertiary)
Time Frame
4 months
Title
Parkinson's Disease quality of life questionnaire (PDQL) (tertiary)
Time Frame
8 months
Title
Self-assessment Parkinson's Disease disability scale (SPDDS)(tertiary)
Time Frame
8 months
Title
Caregiver burden assessed with BELA-A-k, SF-36, and HADS (tertiary)
Time Frame
8 months
Title
Number of injurious falls (secondary)
Time Frame
8 months
Title
Number of patients with injurious falls (secondary)
Time Frame
8 months
Title
Freezing of gait (tertiary)
Time Frame
8 months
Title
Costs (secondary)
Time Frame
8 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients with idiopathic Parkinson's Disease, diagnosed according to the Brain Bank criteria of the UK Parkinson's Society Regular control by the neurologist Living independently in the community Able to complete the trial questionnaires An increased risk for falling, defined as: at least one fall in the preceding 12 months OR recurrent (monthly) near falls in the preceding 12 months OR fear of falling OR (iv) avoidance of activities due to fear of falling OR a combination of these findings Exclusion Criteria: Atypical parkinsonian syndromes Hoehn and Yahr stage 5 Severe cognitive impairment (MMSE < 24) Severe co-morbidity (e.g., cancer) Planned surgical procedure for PD within the intervention period Patients who have already visited the Multidisciplinary Assessment Center
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marten Munneke, PhD
Organizational Affiliation
UMC St. Radboud
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Bastiaan R. Bloem, MD, PhD
Organizational Affiliation
UMC St. Radboud
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Marjolein A. van der Marck, MSc
Organizational Affiliation
UMC St. Radboud
Official's Role
Principal Investigator
Facility Information:
Facility Name
Ziekenhuis Groep Twente, Twenteborg Ziekenhuis
City
Almelo
Country
Netherlands
Facility Name
Ziekenhuis Rijnstate
City
Arnhem
Country
Netherlands
Facility Name
Wilhelmina Ziekenhuis Assen
City
Assen
Country
Netherlands
Facility Name
Ziekenhuis Groep Twente, Streekziekenhuis Midden-Twente
City
Hengelo
Country
Netherlands
Facility Name
Medisch Centrum Leeuwarden
City
Leeuwarden
Country
Netherlands
Facility Name
Canisius Wilhelmina Ziekenhuis
City
Nijmegen
Country
Netherlands

12. IPD Sharing Statement

Learn more about this trial

Reduction of Falls in the Elderly - Parkinson's Disease

We'll reach out to this number within 24 hrs